Colistimethate
- Generic Name
- Colistimethate
- Brand Names
- Colobreathe, Coly Mycin M, Xylistin
- Drug Type
- Small Molecule
- Chemical Formula
- C58H105N16O28S5
- CAS Number
- 12705-41-8
- Unique Ingredient Identifier
- DL2R53P963
- Background
Colistimethate is an antibiotic that has been shown to have bactericidal activity against aerobic gram-negative microorganisms. Colistimethate is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa.
- Indication
For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly Pseudomonas aeruginosa.
- Associated Conditions
- Bacterial Infections
- Associated Therapies
- -
Pharmacokinetics of Colistin in Critically-ill Patients With AKI Who Receive SLED
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2022-11-28
- Lead Sponsor
- Mahidol University
- Target Recruit Count
- 13
- Registration Number
- NCT05586438
- Locations
- 🇹ðŸ‡
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI)
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT01844778
- Locations
- 🇬🇧
Novartis Investigative Site, Newcastle upon Tyne, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath